111 related articles for article (PubMed ID: 8172816)
1. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation.
Meijerink JP; Goverde GJ; Smetsers TF; Raemaekers JM; Bogman MJ; de Witte T; Mensink EJ
Ann Oncol; 1994; 5 Suppl 1():43-5. PubMed ID: 8172816
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction.
Meijerink JP; Smetsers TF; Raemaekers JM; Bogman MJ; De Witte T; Mensink EJ
Br J Haematol; 1993 Jun; 84(2):250-6. PubMed ID: 8398826
[TBL] [Abstract][Full Text] [Related]
3. Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
Johnson PW; Price CG; Smith T; Cotter FE; Meerabux J; Rohatiner AZ; Young BD; Lister TA
J Clin Oncol; 1994 Apr; 12(4):798-805. PubMed ID: 8151322
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
[TBL] [Abstract][Full Text] [Related]
5. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma.
Lambrechts AC; Hupkes PE; Dorssers LC; van't Veer MB
Blood; 1993 Oct; 82(8):2510-6. PubMed ID: 8400298
[TBL] [Abstract][Full Text] [Related]
6. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant.
Rosenblum MD; Drobyski WR; Keever-Taylor C; Chang CC
Bone Marrow Transplant; 2003 May; 31(10):947-9. PubMed ID: 12748676
[TBL] [Abstract][Full Text] [Related]
7. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
8. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up.
Juckett M; Rowlings P; Hessner M; Keever-Taylor C; Burns W; Camitta B; Casper J; Drobyski WR; Hanson G; Horowitz M; Lawton C; Margolis J; Peitryga D; Vesole D
Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781
[TBL] [Abstract][Full Text] [Related]
9. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of t(14; 18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission.
Lambrechts AC; Hupkes PE; Dorssers LC; van't Veer MB
J Clin Oncol; 1994 Aug; 12(8):1541-6. PubMed ID: 8040665
[TBL] [Abstract][Full Text] [Related]
11. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
Berinstein NL; Reis MD; Ngan BY; Sawka CA; Jamal HH; Kuzniar B
J Clin Oncol; 1993 Jul; 11(7):1344-52. PubMed ID: 8315432
[TBL] [Abstract][Full Text] [Related]
12. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
13. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells.
Yerly-Motta V; Racadot E; Fest T; Bastard C; Ferrand C; Deschaseaux ML; Herve P
Leuk Lymphoma; 1996 Oct; 23(3-4):313-21. PubMed ID: 9031112
[TBL] [Abstract][Full Text] [Related]
14. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
15. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
[TBL] [Abstract][Full Text] [Related]
16. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma.
Hétu F; Coutlée F; Roy DC
Mol Cell Probes; 1994 Dec; 8(6):449-57. PubMed ID: 7700265
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
Hirt C; Dölken G
Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
Darby A; Gribben JG
Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18).
Mandigers CM; Meijerink JP; Raemaekers JM; Schattenberg AV; Mensink EJ
Lancet; 1998 Nov; 352(9139):1522-3. PubMed ID: 9820306
[No Abstract] [Full Text] [Related]
20. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
